These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7483659)

  • 41. Structural motif-based homology modeling of CYP27A1 and site-directed mutational analyses affecting vitamin D hydroxylation.
    Prosser DE; Guo Y; Jia Z; Jones G
    Biophys J; 2006 May; 90(10):3389-409. PubMed ID: 16500955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inherent versatility of P-450 oxygenase. Conferring dehydroepiandrosterone hydroxylase activity to P-450 2a-4 by a single amino acid mutation at position 117.
    Iwasaki M; Darden TA; Parker CE; Tomer KB; Pedersen LG; Negishi M
    J Biol Chem; 1994 Mar; 269(12):9079-83. PubMed ID: 8132645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural determinants of cytochrome P450 substrate specificity, binding affinity and catalytic rate.
    Lewis DF; Eddershaw PJ; Dickins M; Tarbit MH; Goldfarb PS
    Chem Biol Interact; 1998 Oct; 115(3):175-99. PubMed ID: 9851289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural flexibility and functional versatility of mammalian P450 enzymes.
    Negishi M; Uno T; Darden TA; Sueyoshi T; Pedersen LG
    FASEB J; 1996 May; 10(7):683-9. PubMed ID: 8635685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular modelling of mammalian CYP2B isoforms and their interaction with substrates, inhibitors and redox partners.
    Lewis DF; Lake BG
    Xenobiotica; 1997 May; 27(5):443-78. PubMed ID: 9179987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The metabolism of tamoxifen by human cytochromes P450 is rationalized by molecular modelling of the enzyme-substrate interactions: potential importance to its proposed anti-carcinogenic/carcinogenic actions.
    Wiseman H; Lewis DF
    Carcinogenesis; 1996 Jun; 17(6):1357-60. PubMed ID: 8681455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crystal Structure and Functional Characterization of a Cytochrome P450 (
    Kim KH; Lee CW; Dangi B; Park SH; Park H; Oh TJ; Lee JH
    J Microbiol Biotechnol; 2017 Aug; 27(8):1472-1482. PubMed ID: 28633515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular modeling of mammalian cytochrome P450s.
    Friedman FK; Robinson RC; Dai R
    Front Biosci; 2004 Sep; 9():2796-806. PubMed ID: 15353315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural alteration of mouse P450coh by mutation of glycine-207 to proline: spin equilibrium, enzyme kinetics, and heat sensitivity.
    Juvonen RO; Iwasaki M; Sueyoshi T; Negishi M
    Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):31-4. PubMed ID: 8395817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of homology modeling in conjunction with site-directed mutagenesis for analysis of structure-function relationships of mammalian cytochromes P450.
    Szklarz GD; Halpert JR
    Life Sci; 1997; 61(26):2507-20. PubMed ID: 9416773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis.
    Fernandez-Salguero P; Gonzalez FJ
    Pharmacogenetics; 1995; 5 Spec No():S123-8. PubMed ID: 7581481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative modelling of cytochromes P450.
    Kirton SB; Baxter CA; Sutcliffe MJ
    Adv Drug Deliv Rev; 2002 Mar; 54(3):385-406. PubMed ID: 11922954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An expanded, unified substrate recognition site map for mammalian cytochrome P450s: analysis of molecular interactions between 15 mammalian CYP450 isoforms and 868 substrates.
    Zawaira A; Ching LY; Coulson L; Blackburn J; Wei YC
    Curr Drug Metab; 2011 Sep; 12(7):684-700. PubMed ID: 21740382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular modeling of mammalian cytochrome P450s.
    Dai R; Pincus MR; Friedman FK
    Cell Mol Life Sci; 2000 Mar; 57(3):487-99. PubMed ID: 10823248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacophore modeling of cytochromes P450.
    de Groot MJ; Ekins S
    Adv Drug Deliv Rev; 2002 Mar; 54(3):367-83. PubMed ID: 11922953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular modelling of CYP2F substrates: comparison of naphthalene metabolism by human, rat and mouse CYP2F subfamily enzymes.
    Lewis DF; Ito Y; Lake BG
    Drug Metabol Drug Interact; 2009; 24(2-4):229-57. PubMed ID: 20408502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human P450s in the metabolism of drugs: molecular modelling of enzyme-substrate interactions.
    Lewis DF
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):5-8. PubMed ID: 16922648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The sequence homologies of cytochromes P-450 and active-site geometries.
    Lewis DF; Moereels H
    J Comput Aided Mol Des; 1992 Jun; 6(3):235-52. PubMed ID: 1517776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-Function Analysis of Mammalian CYP2B Enzymes Using 7-Substituted Coumarin Derivatives as Probes: Utility of Crystal Structures and Molecular Modeling in Understanding Xenobiotic Metabolism.
    Shah MB; Liu J; Huo L; Zhang Q; Dearing MD; Wilderman PR; Szklarz GD; Stout CD; Halpert JR
    Mol Pharmacol; 2016 Apr; 89(4):435-45. PubMed ID: 26826176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced Catalytic Activity of P450 2A6 Mutants with Coumarin: A Computational Investigation.
    Li W; Ode H; Hoshino T; Liu H; Tang Y; Jiang H
    J Chem Theory Comput; 2009 May; 5(5):1411-20. PubMed ID: 26609728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.